The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2017008631
PubMed Identifier: 29296800
Publication URI: http://europepmc.org/abstract/MED/29296800
Type: Journal Article/Review
Volume: 1
Parent Publication: Blood advances
Issue: 19
ISSN: 2473-9529